Equine papillomavirus type 1: complete nucleotide sequence and characterization of recombinant virus-like particles composed of the EcPV-1 L1 major capsid protein

被引:36
作者
Ghim, SJ
Rector, A
Delius, H
Sundberg, JP
Jenson, AB
Van Ranst, M [1 ]
机构
[1] Univ Louvain, Rega Inst Med Res, Dept Microbiol & Immunol, Lab Clin & Epidemiol Virol, Louvain, Belgium
[2] Univ Louisville, Hlth Sci Ctr, John Graham Brown Canc Ctr, Lab Vaccinol, Louisville, KY 40292 USA
[3] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany
[4] Jackson Lab, Bar Harbor, ME 04609 USA
关键词
papillomavirus; Equus caballus; equine; virus-like particles;
D O I
10.1016/j.bbrc.2004.09.154
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Equus caballus papillomavirus type I (EcPV-1) was isolated from a cutaneous papilloma, the most common neoplasm in horses. The complete EcPV-1 nucleotide sequence and genomic organization were determined. Phylogenetic analysis showed that EcPV-1 is a close-to-root papillomavirus, with only distant relationships to the fibropapillomaviruses and the benign cutaneous papillomaviruses. To produce EcPV-1 virus-like particles (VLPs), the EcPV-1 L1 major capsid protein was expressed in insect cells using a recombinant baculovirus vector. The self-assembled EcPV-1 VLPs were morphologically indistinguishable from wild type papillomavirus virions. Monoclonal antibodies were developed against intact and denatured EcPV-1 VLPs. When tested by ELISA, all monoclonal antibodies produced against intact (#18) and some against denatured EcPV-1 VLPs (#16) reacted with intact EcPV1 VLPs only, demonstrating that the VLPs carry type-specific conformational as well as linear epitopes on their surface. Recombinant EcPV-1 VLPs offer the potential of a noninfectious vaccine to prevent and eradicate equine cutaneous papillomatosis. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1108 / 1115
页数:8
相关论文
共 42 条